Abstract: Paper presents the model reference adaptive control applied for the glucose concentration control in Type 1 diabetes mellitus (T1DM) subject. The adaptive controller structure allows to present the commanded insulin infusion by means of the basal infusion rate and the bolus insulin doses. T1DM simulation model is adjusted so that the simulated output corresponds to the particular data logged in a diabetic diary. These facts have allowed to compare the obtained results with the data logged in the diary.
INTRODUCTION
System for an automated insulin administration for a Type 1 Diabetes Mellitus (T1DM) subject is currently under intense research. One of the sections at the 18th World Congress of the International Federation of Automatic Control (IFAC) was entitled Modeling and control for the artificial pancreas: A new era in glucose regulation of people with type 1 diabetes mellitus. Also this fact indicates that the research intensity of control algorithms of the blood glucose concentration control has grown in recent years.
of sensor. A subcutaneous insulin delivery systems or an insulin pumps have been used in the everyday practice even longer time. The insulin pump serves as an actuator of the artificial pancreas.
The third integral part of the artificial pancreas is the control algorithm itself. In recent years the in silico trials and simulations play an important role in the development and evaluation of different control algorithms for the artificial pancreas Herrero et al. (2013) . Such the simulations are based on a large-scale T1DM model, the description of which may be found for instance in Man et al. (2006) ; Lehmann et al. (2011) ; Wilinska and Hovorka (2008) ; Eren-Oruklu et al. (2009) , and their references. On the other hand, the control algorithm design itself is usually based on the less complex model, for example see Ben Abbes et al. (2011) .
In this paper, the model by Chara Dalla Man and coworkers is considered, see De Nicolao et al. (2011) , and used as a T1DM simulator. T1DM simulator is adjusted so that the simulated output corresponds to the particular data logged in a diabetic diary by the T1DM subject. Consequently, the adaptive controller, based on a Model Reference Adaptive Control (MRAC) theory, for example see Tárník and Murgaš (2011) , as a part of the simulated closed-loop system is evaluated by means of the adjusted T1DM simulator. The same meal protocol as logged in the diabetic diary is considered in the closed-loop system simulation. This allows to compare the insulin administration provided by the T1DM subject itself with the insulin infusion commanded by the adaptive controller.
DIABETIC DIARY
This section summarizes the data logged in the diabetic diary which are consequently used for the T1DM simulator adjustment. Table 2 . For convenience, the data are also graphed in Fig. 2 .
T1DM SIMULATOR ADJUSTMENT
There are two primary information in the diabetic diary that can be directly used for the model adjustment. First the body weight of the subject. In this case the subjects' body weight is close to the model default value (78 kg) Man et al. (2006) . Nevertheless, BW = 75 [kg] is used in the adjusted T1DM model.
Further the Actrapid type insulin is used as mentioned above. Therefore the corresponding subsystem of the model has to be adjusted to represent this type of insulin. Particularly the subcutaneous insulin kinetics subsystem since the time the insulin takes to reach the circulatory apparatus is given by this subsystem. The subsystem equations are in the form, see Man et al. (2007) Magni et al. (2007) ) and rate constants k a1 , k d , k a2 are the subsystem parameters. (2006) with the model output.
The insulin is given at time t = 60 minutes. Further, the original data in insulin units [mU] are converted to picomols using the conversion ratio 1 mU = 6 pmol of insulin.
The pharmacokinetic profile corresponds to a part of model which consist of Subcutaneous Insulin Kinetics Subsystem and Insulin Subsystem. Input is the signal v(t) [pmol/kg/min] and the output is the plasma insulin concentration I(t) [pmol/l] . This part of the model is schematically shown in Fig. 4 . However the parameters of insulin subsystem remain unchanged with model default values. As mentioned only the subcutaneous insulin parameters are adjusted.
The signal v(t) [pmol/kg/min] is considered in the form
where v b is the basal subcutaneous insulin infusion rate. In the view of (1), it follows that in the steady state v b = S cb ,where S cb is the steady state value of the signal S(t), i.e. the subcutaneous insulin subsystem does not influence the basal concentration of the insulin.
The basal insulin concentration is I b = 90 [pmol/l], see Fig. 3 . It can be shown that
where the analogous notation as in Man et al. (2007) To adjust the parameters the nonlinear least-squares problem solver as implemented in Matlab TM has been used. The error function has been simply the difference between the original data-vector and the model output at exactly the same time instants. The optimization result is shown in Fig. 3 Further, the basal glucose concentration value G b has to be chosen. Since during a night the subject is considered in the steady state, the morning glycemia measurements have been used to determine the basal glucose concentration. In this case
Finally, since there is no way how to determine the basal endogenous glucose production EGP b from the diary data, the value proposed in the original articles Man et al. (2007 Man et al. ( , 2006 A further adjustment concerns an insulin sensitivity. There are two types of the insulin sensitivities, which are referred as a peripheral insulin sensitivity V mx and a hepatic insulin sensitivity k p3 , see Man et al. (2007 Man et al. ( , 2006 . These parameters can be set as a percentage of the normal (or mean) values similarly as in Man et al. (2007) . The adjustment of the sensitivity parameters is done in two steps. In the first step the percentage of the both sensitivities is chosen. In the second step the so-called VMX-profile is chosen. The VMX-profile assigns the percentage of the V mx constant value to each hour of the day.
In order to find the sensitivity values a fit-function as a sum of squared errors between the blood glucose measurements and the model output has been considered. However, the records where the glucose concentration is equal to or lower than 7 mmol/l have been neglected since the T1DM model has found to be unable to reflect the short hypoglycemic periods logged in the diary. As a result the T1DM model is adjusted so that the 65% of V mx normal value and 65% of k p3 normal value is chosen for the subsequent simulations. Further a sensitivity factor SF (t), which is graphed in Fig. 5 is considered. Therefore the resulting peripheral insulin sensitivity is time-variant in the form 0.65 V mx SF (t) where V mx is the normal value of this parameter as reported in Man et al. (2006) . The resulting VMX-profile is given by the SF (t) as shown in Fig. 5 , which is chosen as an approximate inverse of the (normalized) insulin basal rate pattern.
To be able to compare the measured glycemia with the simulation the measurement accuracy has to be taken into account. A Standards organizations and a professional societies differ on accuracy acceptability criteria, as discussed in Tonyushkina and Nichols (2009) . In this work the International Organization for Standardization and the U.S. Food and Drug Administration performance criteria are considered. Both are the same. The accuracy criteria is set to ±1.11 mmol/l (±20 mg/dl) for levels < 5.6 mmol/l (< 100 mg/dl) or ±20% for glucose levels ≥ 5.6 mmol/l (≥ 100 mg/dl) for at least 95% of results, see Tonyushkina and Nichols (2009) .
The simulation results of the adjusted T1DM simulator are shown in Fig. 6 . The diary data, particularly the carbohydrates and the insulin bolus serve as the part of the model input. Further, the basal insulin pattern is considered and the insulin sensitivity parameters are adjusted as mentioned above.
ADAPTIVE CONTROLLER
In this section, the adaptive controller based on the principles of the model reference adaptive control is briefly presented.
The controller design is based on the simplified T1DM subject model. The subject is modeled as a time-delay Fig. 7 . Controlled system system with two inputs and one output, see Ludwig et al. (2013) ; Tarnik et al. (2013) . The controlled system is considered in the form of transfer function, which can be identified in the operating point given by the steady-state rate of the insulin infusion, see Ludwig et al. (2013) .
The transfer function is in the form
where a 0 , a 1 , b 0 and Ψ ⋆ ∈ R 3 are in general the unknown system parameters. The time-delay τ is assumed to be known, Tarnik et al. (2013) . Further, the signal ∆G M (t) [mmol/l] is the deviation of the subcutaneous glucose concentration from the steady-state value and ∆v(t) [pmol/kg/min] is the deviation of the steady-state insulin infusion rate. The signal w
where the signal d(t)
[mg/min] is a meal ingestion rate and the time-delays τ 1 and τ 2 are assumed to be known. The meal announcement information availability is assumed as common in the conventional diabetes therapy. Finally the system order n = 2 and the relative degree n ⋆ = 2 are known and the sign of the parameter b 0 is also known. The controlled system is schematically shown in Fig. 7 .
In general, the control objective is given by the reference model in the form y m (s) = W m (s)r(s), where W m (s) is the reference model transfer function, y m (t) is the reference model output and r(t) is the reference signal.
The proposed adaptive controller consists of two parts. The first, a classical MRAC based controller and the second an adaptive disturbance rejection controller.
The control law of the MRAC based part can be written in the form
is the vector of adapted parameters. The signal vector ω(t) has the form ω
where the auxiliary signals ν 1 (t), ν 2 (t) ∈ R n−1 are given in the forṁ
where
is an arbitrary stable matrix.
An adaptation law has the forṁ Θ(t) = sgn(b 0 )σ Θ Θ(t) − sgn(b 0 )Γ 1 e a1 (t)ω f (t) (7) where An augmented error signal is given in the form
where the signal y a (t) is the output of the Smith-predictorlike filter in the form
where ρ(t) is the adapted parameter given by the adaptation law in the forṁ
(11) where
and
The adaptive disturbance rejection is based on the meal ingestion rate signal, i.e. on the disturbance signal d(t), as follows. In order to compensate the disturbance the signal ∆v(t) is in the form ∆v(t) = u(t) − u d (t), where
The adapted parameters Ψ(t) ∈ R 3 are given by the adaptation laẇ
where Ψ max and σ Ψ0 are the design constants. This adaptation law can be considered as a gradient based with a switching σ-modification.
CLOSED-LOOP SYSTEM SIMULATION
The aim of this section is to compare the insulin administration logged in the diabetic diary with the insulin infusion commanded by the adaptive controller. First the following scenario is simulated. The time period of eight days is considered, therefore the meal protocol and the insulin protocol logged in the diabetic diary is repeated two times. The meal data and the insulin data from the diabetic diary serve as the input to the adjusted T1DM simulator. Same basal insulin pattern as in Fig. 1 is considered and the insulin sensitivity as depicted in Fig. 5 is used. The simulation results are shown in Fig. 8 . The dashed line shows the results for the case when the insulin is administered as given in the diabetic diary.
The time period of eight days is also considered in the closed-loop system simulation. The general settings of the controller for this case have found to be as follows. , σ Ψ0 = −0.0001 and Ψ max = 0.004.
Finally, the adapted parameter initial values in all adaptation laws equal zero.
Simulation results for the case when the insulin administration is given by the adaptive control algorithm are shown in Fig. 8 (solid line).
CONCLUSION
From the diabetes compensation point of view, the control objective is to keep the glucose concentration in the normal glycemia range (4 -10 mmol/l) for the most of the time. For the simulation results, where the insulin is given by the diabetic diary, 64% of the time the simulated glycemia has been higher than 10 mmol/l and 36% of the time lower or equal than 10 mmol/l.
As Fig. 8 indicates, in the case No.2, where the insulin has been commanded by the adaptive controller, better results have been obtained. The glycemia has been higher than 10 mmol/l only for 31% of the simulation time. The rest of the time the glycemia has been equal to or lower than 10 mmol/l including 1% of the time for which the glycemia has been lower than 4 mmol/l. However the observed hypoglycemic period in the first simulated day can be attributed to the controller adaptation process. Therefore such a insignificant hypoglycemic event can be avoided by an appropriate choice of the adapted parameter initial values (not reported in the paper).
Besides the achieved tight glucose control a significant variability of the basal insulin rate in comparison with the basal insulin pattern logged in the diabetic diary has been observed as well as the bigger bolus doses. Also this illustrates the use of the in-silico experiment in the control algorithm design.
